Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website
Subscribe CustomBlackClose

Belt & Road Weekly Subscription Form

download_pop

Research ReportCustomBlackClose

The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.

Click on the button below to create your account and get immediate access to thousands of articles.

Start a Free Trial

Xinhua Silk Road Database
Company

New Horizon Health partners with Prenetics on ColoClear

May 24, 2022


Abstract : New Horizon Health Limited (06606.HK) and Nasdaq-listed Prenetics Group Limited on Monday announced a strategic partnership to promote ColoClear by Circle (ColoClear) and launch ColoClear in China's Hong Kong market.

XxjpbeE007022_20190822_PEPFN0A001_500x500.JPG

Tourists visit the Peak Hong Kong scenic spot in south China's Hong Kong, Aug. 20, 2019. (Xinhua/Lu Hanxin)

BEIJING, May 24 (Xinhua) -- New Horizon Health Limited (06606.HK) and Nasdaq-listed Prenetics Group Limited on Monday announced a strategic partnership to promote ColoClear by Circle (ColoClear) and launch ColoClear in China's Hong Kong market.

The two sides will jointly promote ColoClear, a proprietary non-invasive stool-based FIT-DNA test for colorectal cancer screening independently developed by New Horizon Health, in the markets of China's Hong Kong, Macau and Taiwan, with future option of an expanded partnership for Southeast Asian markets, according to the agreement.

ColoClear's official launch date for the Hong Kong market is currently set for June 8, 2022.

It is noted that Prenetics will have the exclusive rights to provide ColoClear laboratory testing service and the profits from the sales of ColoClear will be shared 50/50 between New Horizon Health and Prenetics, according to the terms of the agreement.

New Horizon Health, founded in 2015, is a Chinese biotechnology company focusing on early cancer screening. The company went listed on Hong Kong stock exchange in February 2021.

Prenetics is a Hong Kong-based biotech company which went floated on Nasdaq on May 18, 2022 through a merger with Artisan Acquisitio Corp. (Edited by Zhong Xinpei, Niu Huizhe with Xinhua Silk Road, niuhuizhe@xinhua.org)

Scan the QR code and push it to your mobile phone

Keyword: New Horizon Health Prenetics colorectal cancer screening

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to [email protected] and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial

Ask Us A Question belt & road login close

If you have any questions, please enter them in the box below.

Identifying code Reload

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial